Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study

OBJECTIVE: To estimate the effectiveness of the three covid-19 vaccines by Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273), and Oxford-AstraZeneca (ChAdOx1-S) in people after receiving two doses. DESIGN: Cohort study. SETTING: Nationwide, population based data in France, from the French National Hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouillon, Kim, Baricault, Bérangère, Botton, Jérémie, Jabagi, Marie-Joëlle, Bertrand, Marion, Semenzato, Laura, Le Vu, Stéphane, Drouin, Jérôme, Dray-Spira, Rosemary, Weill, Alain, Zureik, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978755/
https://www.ncbi.nlm.nih.gov/pubmed/36936561
http://dx.doi.org/10.1136/bmjmed-2021-000104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978755/
https://www.ncbi.nlm.nih.gov/pubmed/36936561
http://dx.doi.org/10.1136/bmjmed-2021-000104

Ejemplares similares